- Number of comorbidities over the study period and occurrence in different fungal species.
| Comorbidities | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | Mold | Non-C. albicans | C. albicans | Total | (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unknown | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | (0.6) |
| Respiratory | 0 | 0 | 4 | 1 | 36 | 39 | 18 | 0 | 0 | 9 | 10 | 38 | 59 | 107 | (30) |
| Oncology | 0 | 0 | 1 | 1 | 13 | 26 | 0 | 0 | 0 | 5 | 3 | 30 | 13 | 46 | (13) |
| Kidney disease | 0 | 0 | 7 | 0 | 6 | 1 | 0 | 0 | 0 | 0 | 2 | 6 | 6 | 14 | (4) |
| Coma, unspecified | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 6 | (1.7) |
| Fever, unspecified | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 6 | 6 | (1.7) |
| Hypokalemia | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 6 | (1.7) |
| Gastrointestinal | 1 | 1 | 1 | 1 | 18 | 0 | 6 | 4 | 5 | 11 | 3 | 23 | 22 | 48 | (14) |
| Lower limb injury and diabetes | 0 | 0 | 0 | 0 | 19 | 0 | 11 | 6 | 9 | 10 | 0 | 42 | 13 | 55 | (16) |
| Cardiovascular disease | 0 | 0 | 0 | 0 | 16 | 6 | 6 | 0 | 0 | 0 | 1 | 12 | 15 | 28 | (8) |
| Amoebic infection of other sites | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 4 | 4 | (1.1) | |
| Sepsis, unspecified | 0 | 0 | 1 | 0 | 1 | 9 | 0 | 5 | 0 | 0 | 1 | 12 | 3 | 16 | (4.5) |
| Accidents | 0 | 0 | 1 | 0 | 0 | 2 | 0 | 5 | 0 | 0 | 2 | 0 | 6 | 8 | (2.3) |
| Urinary tract infection, site not specified | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 6 | (1.7) |
| Grand total | 2 | 1 | 21 | 3 | 115 | 90 | 47 | 24 | 14 | 35 | 23 | 179 | 150 | 352 | (100) |
| Percentage | 0.57 | 0.28 | 5.97 | 0.85 | 32.7 | 26 | 13.4 | 6.82 | 3.98 | 9.94 | 6.53 | 50.9 | 42.61 | 100 | 28 |